Contributor Disclosures for Paroxysmal Supraventricular Tachycardia

Role Name Disclosure Details Author  Monika Gugneja, MD, Consulting Staff, Department of Emergency Medicine, William Beaumont Hospital Nothing to disclose Details Coauthor  James V Talano, MD, MM, FACC, Director of Cardiovascular Medicine, SWICFT Institute Nothing to disclose Details Medical Editor  Alan D Forker, MD, Professor of Medicine, Program Director of Cardiovascular Fellowship, Department of Medicine, Mid America Heart Institute, University of Missouri at Kansas City School of Medicine; Codirector, Lipid Diabetes Research Center, Saint Luke's Hospital Nothing to disclose Details Pharmacy Editor  Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine Nothing to disclose Details Managing Editor  Brian Olshansky, MD, Professor of Medicine, Director of Cardiac Electrophysiology, Department of Internal Medicine, University of Iowa Hospitals Guidant/Boston Scientific Medtronic Guidant/Boston Scientific Reliant Novartis Novartis Details CME Editor  Amer Suleman, MD, Consultant in Electrophysiology and Cardiovascular Medicine, Department of Internal Medicine, Division of Cardiology, Medical City Dallas Hospital Nothing to disclose Details Chief Editor  Nothing to disclose Details Contributor Disclosure Contributor: Contributor Disclosure: Monika Gugneja, Author  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: James V Talano, Coauthor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Alan D Forker, Medical Editor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Francisco Talavera  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Brian Olshansky  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Guidant/Boston Scientific Honoraria Speaking and teaching   Medtronic Honoraria Speaking and teaching   Guidant/Boston Scientific Consulting fee Consulting   Reliant Grant/research funds Other   Novartis Honoraria Speaking and teaching   Novartis Consulting fee Consulting   Off label or investigational use of medication Contributor Disclosure Contributor: Contributor Disclosure: Amer Suleman, CME Editor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Paul Mounsey, Chief Editor  The contributor discloses no conflict of interest.